Skechers Performance Partners with Breast Cancer Care to Support People Affected by Breast Cancer

Skechers Performance releases a footwear collection and marketing
campaign to support Breast Cancer Awareness Month

LONDON–(BUSINESS WIRE)–Skechers Performance™, a division of SKECHERS USA, Inc. (NYSE:SKX), is
thrilled to announce its 2016 partnership with Breast Cancer Care, the
only specialist UK-wide charity providing support for anyone affected by
breast cancer. For the first time in the United Kingdom, Skechers
Performance will launch a two-month marketing programme that includes
in-store, digital, print and social media executions. To commemorate the
partnership, Skechers Performance is releasing a limited edition
footwear collection marked with the iconic breast cancer awareness pink
ribbon, which will be available in SKECHERS retail stores and online,
late September 2016.

“We are proud to partner with Breast Cancer Care and help their cause,
providing care, support and information to help thousands of people to
find a way to live with, through and beyond breast cancer.” said Peter
Youell, SKECHERS UK & Ireland Managing Director. “After seeing the
success of previous partnerships, we wanted to continue and expand our
support for breast cancer charities in the United Kingdom. In this new
collaboration we wish to help raise awareness about all the incredible
free services that Breast Cancer Care provide, including face-to-face
support, vital information and the confidential Helpline.”

The Skechers Performance Breast Cancer Care collection includes the
Skechers GOrun 400 and GOwalk 3™ styles, and will retail for £59.00. A
donation of £5 per pair sold will be donated to the foundation. The
designs incorporate a black, white and charcoal colour pallet with the
classic pink hue weave-in. Each style also features the pink ribbon
detailing on the heel.

The Skechers GOwalk 3 shoe is available in a slip-on style and features
Skechers’ iconic Goga Mat® technology in the footbed. The shoe also has
responsive flexibility for a more natural movement and incorporates Goga
Pillars™ for added comfort.

Skechers GOrun 400 is designed to be light, comfortable and well
cushioned. The 5GEN® midsole material combined with a biometric design
and breathable mesh upper delivers comfort for your workout. The shoe is
also lined with a unique Goga Run® insole that provides shock absorption
and support.

The limited edition Skechers Performance Breast Cancer Care line is
available at SKECHERS retail stores in the United Kingdom and online at throughout October. The funds raised will support Breast
Cancer Care, the only specialist UK wide charity providing support for
women, men, family and friends affected by breast cancer.

Notes to Editor

To learn more about Breast Cancer Care visit

Learn more about Skechers Performance visit
and follow us on Facebook (, Twitter


SKECHERS USA, Inc., based in Manhattan Beach, California, designs,
develops and markets a diverse range of lifestyle footwear for men,
women and children, as well as performance footwear for men and women.
SKECHERS footwear is available in the United States and over 160
countries and territories worldwide via department and specialty stores,
more than 1,410 SKECHERS Company-owned and third-party retail stores,
and the Company’s e-commerce website. The Company manages its
international business through a network of global distributors, joint
venture partners in Asia, and wholly-owned subsidiaries in Brazil,
Canada, Chile, Japan, Latin America and throughout Europe. For more
information, please visit
and follow us on Facebook (
and Twitter (

This announcement contains forward-looking statements that are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements include,
without limitation, the Company’s future domestic and international
growth, financial results and operations including expected net sales
and earnings, its development of new products, future demand for its
products, its planned domestic and international expansion and opening
of new stores, the completion of the expansion and upgrade of the
Company’s European Distribution Center, and advertising and marketing
initiatives. Forward-looking statements can be identified by the use of
forward-looking language such as “believe,” “anticipate,” “expect,”
“estimate,” “intend,” “plan,” “project,” “will be,” “will continue,”
“will result,” “could,” “may,” “might,” or any variations of such words
with similar meanings. Any such statements are subject to risks and
uncertainties that could cause actual results to differ materially from
those projected in forward-looking statements. Factors that might cause
or contribute to such differences include international economic,
political and market conditions including the uncertainty of sustained
recovery in Europe; entry into the highly competitive performance
footwear market; sustaining, managing and forecasting costs and proper
inventory levels; losing any significant customers; decreased demand by
industry retailers and cancellation of order commitments due to the lack
of popularity of particular designs and/or categories of products;
maintaining brand image and intense competition among sellers of
footwear for consumers; anticipating, identifying, interpreting or
forecasting changes in fashion trends, consumer demand for the products
and the various market factors described above; sales levels during the
spring, back-to-school and holiday selling seasons; and other factors
referenced or incorporated by reference in the Company’s annual report
on Form 10-K for the year ended December 31, 2015 and its quarterly
report on Form 10-Q for the three months ended June 30, 2016. The risks
included here are not exhaustive. The Company operates in a very
competitive and rapidly changing environment. New risks emerge from time
to time and the companies cannot predict all such risk factors, nor can
the companies assess the impact of all such risk factors on their
respective businesses or the extent to which any factor, or combination
of factors, may cause actual results to differ materially from those
contained in any forward-looking statements. Given these risks and
uncertainties, you should not place undue reliance on forward-looking
statements as a prediction of actual results. Moreover, reported results
should not be considered an indication of future performance.

About Breast Cancer Care

When you have breast cancer, everything changes. Time becomes measured
in appointments. The next scan. The next results. The next challenge.

At Breast Cancer Care, we understand the emotions, challenges and
decisions you face every day. So, from the day you notice something’s
not right to the day you begin to move forward, we’ll be here to help
you through.

Whether you want to speak to our nurses, download our specialist
information or connect with volunteers who have faced what you are
facing now, we can help you feel more in control.

For care, support and information from day one, call us free on 0808 800
6000 or visit

# # #


Nicola Zachariades
655 955